At Fierce Healthcare, we keep track of all the venture capital being funneled into the health tech and digital health industries.
Our fundraising tracker provides updated coverage of noteworthy digital health and health tech funding rounds, though we'll still profile exciting new companies and larger rounds that catch our eye in depth.
Do you have fundraising news to share? Email Heather Landi at hlandi@questex.com.
May
May 13—9amHealth
Virtual specialty care platform targeting high-cost chronic conditions
Series: B
Amount: $26 million
Investors: Led by Define Ventures, with participation from SemperVirens VC, Catalio Capital Management and NewHealth Ventures
Virtual specialty care platform 9amHealth is expanding its offerings into chronic conditions with a $26 million series B funding round.
Founded in 2021, the company has developed a clinical infrastructure, care delivery model and technology platform needed to manage complex, high-cost chronic conditions at scale. It has partnered with large enterprise employers and pharmaceutical companies for its virtual cardiometabolic care, including support for patients with obesity, diabetes, hypertension and hyperlipidemia. It says it has generated more than $50 million in medical and pharmacy savings across two Fortune 100 employers.
"What makes this possible is our ability to combine specialized clinical care with AI-enabled clinical workflows and personalized member experiences that allow us to scale efficiently across complex chronic conditions," said Frank Westermann, 9amHealth CEO and co-founder, in a statement. "We've already proven this model in cardiometabolic care, and are now extending to a much broader set of high-cost needs."
It plans to use the new funding to continue its growth as it expands into specialty-level chronic conditions that are typically high cost, collectively accounting for up to 70% of employer pharmacy spend. Release
May 13—Anomaly Insights
Expand AI-driven RCM operations platform
Amount: $17 million
Investors: Led by Sound Ventures, with participation from Alumni Ventures, Link Ventures, Redesign Health and RRE Ventures
AI-powered payer intelligence company Anomaly Insights is expanding its platform from revenue cycle operations into managed care, aiming to give providers insight across "every contract negotiation and claims interaction" with insurance companies.
The AI-driven platform performs real-time analysis of billions of healthcare transactions to provide information on payer patterns, policy shifts and adjudication deviations. The company says the tool has recovered tens of millions in provider revenue, producing measurable payer behavior changes, for various healthcare organizations and systems to date.
"Providers have known intuitively for years that the system is rigged against them," said Mike Desjadon, Anomaly Insights CEO, in a statement. "What they've never had is the intelligence to prove it, and a partner to 'bring the receipts' and help them act on it, and finally change payer behavior. This funding accelerates our ability to give healthcare organizations something they have never had before: a platform that demonstrates how their payers actually behave, and the leverage to engage them as equals when it comes to contesting payment issues or contract negotiations."
Anomaly Insights has raised $34 million to date. Release
May 12—Knit Health
AI-driven clinical behavior model for operations, care optimization
Series: seed
Amount: $11.6 million
Investors: Led by Moxxie Ventures, with participation from Coalition Operators
Health tech company Knit Health launched from stealth with an $11.6 million in seed funding as it seeks to accelerate development and deployment of its AI-driven clinical behavior model to optimize operations and patient care.
Founded in 2025 out of UC Berkley, Knit Health’s Large Clinical Behavior Model (LCBM) is built from Truveta EMR Data from over 130 million patients across 30 U.S. health systems. The company says the model learns directly from clinical decision-making patterns, which it then applies across operational and care delivery workflows.
"Much of what matters most in medicine isn’t written in textbooks, it’s learned through experience with time and navigating the healthcare system," said Jonathan Kolstad, Knit Health CEO and co-founder, in a statement. "Across millions of patient journeys, clinicians develop patterns for what to do next and when. Knit learns from those real-world decisions, transforming collective clinical experience into intelligence that improves how the system works." Release
May 5—XCaliber Health
Agentic operating system for healthcare
Series: seed
Amount: $6.5 million
Investors: Led by ManchesterStory with participation from Benhamou Global Ventures (BGV) and Arka Venture Labs
XCaliber Health is building an agentic AI platform designed to reduce administrative burden in healthcare by creating semi-autonomous healthcare enterprises. Unlike point solutions that automate in isolation, XCaliber connects every system a provider touches and orchestrates work across all of them in real time, according to executives.
The startup's platform also offers pre-built agents for interoperability, healthcare analytics, scheduling, prescription refills and other tasks.
XCaliber Health processes more than eight million chart updates and generates more than 160,000 electronic health record (EHR) updates daily across more than 700,000 unique patients.
Health systems, provider groups and digital health companies use XCaliber to replace manual, fragmented workflows, from prescription refill and referral coordination to lab notifications and care gap management, with autonomous execution that has humans in the loop. For prescription refills alone, XCaliber's patient navigator agent saves providers an average of six hours of manual, repetitive work every day, time that goes directly back to patient care, according to executives.
Staff spend an average of 15.5 hours per physician, per week on record retrieval, prior authorization, referral coordination, scheduling and clinical documentation. At a 20-provider practice, that translates to $1.4 million in annual costs from manual workflows, scheduling gaps, prior authorization delays, and reactive patient outreach.
"Healthcare does not need more disconnected point solutions. It needs a system that can coordinate work across all of them and take the administrative burden off clinical and operational teams," said Prakash Khot, co-founder and CEO of XCaliber in a statement. "That is where XCaliber is focused. We are helping healthcare organizations move beyond manual work toward automated workflows that reduce costs, accelerate care delivery, and give clinical teams back the time to focus on patients. We're honored to be backed by investors who believe in our mission to fundamentally reshape how healthcare operates."
The startup says it will use the the fresh seed funding to accelerate product development and scale the platform across organizations nationwide. Release
May 4—Enzo Health
AI-driven home health platform
Series: series A
Amount: $20 million
Investors: Led by N47 with participation from Gradient, Tandem Ventures, and Rigby Watts
Enzo Health aims to use AI to automate and streamline every piece of the post-acute care process. The startup's AI-driven platform automates and connects home health and post-acute care providers' front office, clinical operations and back office functions in one system, handling the entire workflow from referral to reimbursement while minimizing regulatory risk.
Where legacy home health software left agencies cobbling together disconnected point solutions and incurring unnecessary costs and time spend, Enzo Health's solution bolsters care providers' margins, returns precious hours to nurses and clinicians and allows patients to receive care in the settings in which they are most comfortable, according to the company.
Enzo's AI-driven platform includes an intake feature that analyzes referrals instantly, converts faxes, emails and PDFs into structured data, and checks eligibility in seconds before staff review is needed and a scribe to deliver AI-assisted documentation in real-time during a visit. Enzo's QA feature continuously reviews charts for clinical and regulatory accuracy, catching issues before they affect reimbursement or compliance, the company said.
Enzo Health has raised $26 million to date. The fresh funding positions Enzo to meet surging demand for in-home care, which is accelerating as more than 10,000 Americans turn 65 every day, executives said. The company plans to use part of the funds from its series A to expand into the skilled nursing and hospice sectors.
Launched in 2024, Enzo Health says it has grown revenue by more than 40X in twelve months and is now used by organizations that support over 500,000 patients annually.
Seven out of 10 Americans will require long-term care at some point in their lifetime, according to the U.S. Department of Health and Human Services. With 73 million Baby Boomers increasingly gravitating toward home health, jobs in the sector are expected to grow by roughly 17% from 2024 to 2034, according to the Bureau of Labor Statistics.
According to the Home Care Association of America, home health clinician turnover hovers near 80% within the first 100 days, as nurses and clinicians are frequently forced to work long hours to keep up with documentation for billing, regulatory compliance and quality assurance at the same time as they care for patients. Release
April
April 30—Greatly Health
Closing integrative care gaps in oncology care
Series: Seed
Amount: $4 million
Investors: Co-led by Pear VC and Commonweal Ventures, with participation from Flare Capital Partners and strategic investors
The startup says its building a new category of cancer care by integrating evidence-based supportive therapies, such as exercise, nutrition and mind-body interventions, directly into the treatment journey. While these approaches are recommended in oncology guidelines to address symptom burden, access remains limited and fragmented outside major institutions, executives said.
Greatly's model is based on a virtual program that was originally developed and clinically validated at Memorial Sloan Kettering Cancer Center (MSK). In a randomized trial and subsequent secondary analyses led by Greatly's co-founders at MSK, the program demonstrated significant improvements in clinical outcomes compared to usual care: 16% absolute improvement in overall survival at two years, 69% reduction in hospitalization rates and 42% reduction in treatment disruptions.
Digital health executive Chip Stine founded Greatly Health, alongside Jun Mao, M.D., Chief of Integrative Medicine and Wellness at MSK, and Robert Daly, M.D., an Associate Attending Physician at MSK and researcher in cancer care delivery innovation.
Greatly Health delivers care through a virtual platform and patients can access live, expert-led group sessions including exercise, yoga, tai chi and mindfulness, along with personalized care planning, symptom tracking and ongoing coaching support. The company emphasizes live, structured, guided participation and continuous engagement. Patients also can participate in live sessions together, reducing isolation and improving adherence.
Greatly is expanding its model through partnerships with health plans, oncology providers and life sciences companies. The company currently serves patients both directly and through sponsored programs. The startup plans to use the new funding to expand its team, enhance its technology platform and broaden its clinical offering to other integrative therapies with supporting evidence. Release
April 23—Gravity Rail
AI-powered patient engagement workflows
Series: Seed
Amount: $2.75 million
Investors: Redesign Health
Gravity Rail launched out of stealth with a platform that enables healthcare organizations and care teams to build and run their own AI-powered patient engagement workflows.
Co-founded by Dan Walmsley, chief technology officer, and Scott Hoch, CEO, Gravity Rail says it brings a fundamentally different approach to deploying AI in healthcare that shifts control from outsourced vendors and point solutions to the teams responsible for patient engagement and care coordination. Rather than offering a single AI agent or outsourced service, Gravity Rail provides a model-agnostic operating system for AI-powered engagement, where healthcare teams can build, certify, and run workflows using their own protocols—across phone, SMS, email, web, and messaging channels—without writing code or relying on implementation vendors.
The platform is designed for any healthcare organization or companies working with them—including health plans, provider organizations, contact centers, business processing organizations, digital health companies, and clinical trial platforms—that are responsible for managing patient and member engagement at scale.
Most AI tools are still deployed as isolated solutions that sit outside operational teams, but as workflows change, those systems quickly fall out of sync.
"Payer rules change, protocols evolve, better models emerge, and updates require coordination with an external vendor. AI transformation has to happen inside the organization. We put control in the hands of the people doing the work, turning protocols into live infrastructure they can see, test, and evolve continuously. As models commoditize, the advantage shifts to the organizations that can adapt fastest," Hoch said in a press release.
In current deployments, Gravity Rai says it has already demonstrated measurable impact. Organizations are connecting with patients 2x to 3x more often while reducing handle times and improving patient satisfaction. Referral workflows have achieved a 30% increase in first scheduled appointment rates compared to manual outreach. Release
April 23—Zócalo Health
Tech-enabled, community-based primary care provider
Series: A
Amount: $15 million
Investors: EO Ventures, with participation from Talipot and existing investors Vamos Ventures, Animo Ventures, Acumen America, Sorenson Ventures, BarronKent, and Kapor Center
Zócalo Health plans to use a new infusion of cash to accelerate nationwide expansion of its tech-enabled primary care services and scale its community-based workforce. The company also plans to deepen partnerships with health plans.
Health plans face growing pressure to manage a small segment of members who drive a disproportionate share of healthcare costs. These patients, with complex medical, behavioral, and social needs, are historically difficult to engage in care. Zócalo Health says it's built specifically for this population, combining community-based care teams with virtual clinical services to drive sustained engagement, improve outcomes and reduce total cost of care within value-based frameworks.
Over the past year, Zócalo Health asserts it has demonstrated strong operating performance and early product-market fit. The company grew revenue approximately 4x year-over-year, expanded from two regional health plan partnerships in 2024 to more than a dozen in 2025, and is entering new markets across multiple states. The model has maintained high member retention, frequent monthly engagement and patient satisfaction scores that significantly exceed industry benchmarks.
Zócalo Health embeds community health workers in the communities they serve. These teams are integrated with primary care providers, behavioral health clinicians and care coordinators, enabling continuous engagement beyond traditional clinic settings.
The company's platform also leverages AI to support and extend the capacity of frontline teams. The platform equips members with better visibility into their coverage and eligibility as well; it supports them alongside their CHWs in navigating Medicaid redetermination and evolving eligibility requirements. Release
April 23— Almanac Health
Research-validated clinical AI platform for physicians
Series: Seed
Amount: $10 million
Investors: Led by F-Prime with participation from General Catalyst and Lightspeed Venture Parnters
Almanac Health, a clinical AI platform founded by a physician, provides evidence-based clinical decision support that integrates with existing electronic health record systems. The fresh funding will advance the company’s mission to bring safe, evidence-grounded AI to clinicians and health systems, executives said.
The company aims to bring specialist-grade knowledge to clinicians at the point of care, providing evidence-based clinical decision support across medical specialties, free from pharmaceutical advertising, and governed by institutional controls. The platform is designed to work within existing EHR systems and grounded in peer-reviewed evidence. The company asserts the platform is currently undergoing rigorous clinical validation in academic medical center settings.
The company was founded by physician-researcher Cyril Zakka, M.D., whose work at Stanford University introduced retrieval-augmented generation to clinical medicine. After earning his MD, Zakka went on to conduct machine learning research at Stanford, where he developed the first retrieval-augmented generation system for clinical medicine, an approach to grounding AI in trusted medical knowledge that has since been widely adopted across clinical AI. That work, published in NEJM AI, became one of the journal’s most-cited papers and established the foundational approach used by most clinical evidence AI products today. He subsequently led health AI at Hugging Face, the largest open-source AI platform, before founding Almanac Health.
The funding will allow the company to grow its team across clinical medicine, AI research, and health systems infrastructure, as well as advance R&D with a focus on privacy, reliability, and rigorous evaluation before deployment. Release
April 22—Courier Health
Patient experience platform and agentic AI capabilities for life sciences companies
Series: B
Amount: $50 million
Investors: Led by Oak HC/FT, with participation from existing investors including Norwest Venture Partners and Work-Bench
Courier Health launched in 2022 with an artificial intelligence-powered platform purpose-built for biopharma that manages the end-to-end patient journey from education to patient enrollment, benefits and prior authorization, through therapy initiation and adherence. Courier Health's AI agents can automate tasks such as, intake, benefits checks and information requests, according to the company.
The startup aims to "rewrite the patient experience in healthcare," starting with simplifying and coordinating complex patient journeys for those who depend on innovative medicines, Danny Sigurdson, founder and CEO of Courier Health, told Fierce Healthcare.
The fresh funding will fuel Courier Health's investment in product innovation, including scaling its agentic AI capabilities, and building out its team as it hires across product, engineering, client solutions and sales, according to executives. Story
April 22—Amperos Health
AI-powered revenue recovery and denial management platform
Series: A
Amount: $16 million
Investors: Uncork Capital, Neo and Nebular, with strategic angel investors from OpenAI, Twilio and Stripe
Amperos Health developed an AI-native, end-to-end denial management platform designed to address inefficiencies in healthcare claims processing.
Amperos Health CEO and co-founder Michal Miernowski told Fierce Healthcare the company plans to use the newly announced funding to scale the existing organization. Alongside the funding announcement, Amperos announced the launch of what the company calls the industry’s first AI-native denial management and revenue recovery end-to-end solution for providers.
The platform uses large language models (LLMs) to complete entire RCM workflows and maximize reimbursement at the lowest cost to collect. Miernowski said feedback on the tool has been positive across entire organizations, citing a large provider with a national footprint that was “severely understaffed.”
The company says it has served more than 3,000 clinical locations across the U.S. to date, driving nearly $700,000 million in recovered revenue per year across more than 500,000 claims. Story
April 21—Tava Health
Tech-driven mental health services
Series: C
Amount: $40 million
Investors: Led by Centana Growth Partners with participation from Catalyst Investors, Blue Heron Ventures, Peterson Ventures, and Springtide Ventures
Tava Health has transitioned from a mental health network into a full-stack behavioral health platform serving providers, employers, and health plans. The company says its in-network for 9 in 10 commercially-insured U.S. patients through integrations with more than 200 health plans across all 50 states, with first-session availability in as little as 12 hours.
"We raised this capital to invest deeply in our partners: the clinicians delivering care and the clinics managing the complexity behind it; the employers making care accessible and affordable for their employees; and the health plans moving beyond access toward real outcomes," Dallen Allred, co-founder and CEO of Tava Health in a statement. "When all three are better supported, the person sitting across from a clinician gets better care."
The fresh funding coincides with the release of three new enhancements to Tava Health’s platform designed to eliminate cost barriers to mental health access: an AI-powered clinic operating system; a zero-budget employer benefit; and a care-navigation suite.
For clinicians and group practices, the company is launching Symphony by Tava Health, a free, AI-assisted practice management platform purpose-built for behavioral health. The platform brings together an AI clinical scribe, AI-assisted treatment planning, integrated scheduling and telehealth, the company said.
TavaCare for Employers gives any organization access to Tava Health's clinical network, plus the Tava Management Console – a free platform for bringing meaningful mental health benefits to their employees. Tava Guide gives health plans, health systems and care coordinators a centralized hub to search for and generate referrals, and track patient progress throughout their care journey, according to the company. Release
April 21—AcuityMD
Intelligence platform for medtech companies
Series: C
Amount: $80 million
Investors: Led by StepStone Group, with participation from Benchmark, Redpoint Ventures, ICONIQ, and Atreides Management
AcuityMD has raised $80 million—with a company valuation now nearing $1 billion—to use its artificial intelligence (AI) platform to boost multiple aspects of how medtech companies operate.
With $160 million in the tank to date, AcuityMD is seeking to set up autonomous systems using AI, known as agentic AI, “for commercial personas, including sales reps, leadership and marketing teams,” the company said, as Fierce Biotech reported.
Looking beyond these areas of focus, the company also wants to use the funds to work more deeply on its “broader mission to accelerate the adoption of medical technology across the full product lifecycle.”
Its main system, known as AcuityAI, is in an open beta phase, which the company said is designed to allow sales reps to “spend less time figuring out where to go and more time in front of the right physicians, armed with the right context to win more business.” Story
April 20—Coral
Healthcare administrative automation for specialty providers
Series: Seed
Amount: $12.5 million
Investors: Lightspeed and Z47
Coral built a healthcare automation platform built for specialty providers. The company says it combines intelligent document processing, agentic workflows and voice automation and then integrates with existing EHR systems, fax lines, and payer portals to automate end-to-end administrative workflows for healthcare providers, including DME suppliers, infusion centers and radiology practices. The platform handles intake, prior authorization, fax processing and patient communications without requiring providers to change how they work, according to the company.
Coral’s models have now reached 99.7% accuracy on the document types that define healthcare’s back office: handwritten fax forms, scanned insurance cards, prior authorization templates, payer portal screens.
Coral is targeting 4x growth before the end of the year, expanding further across existing verticals while moving into radiology and additional specialty categories.
In a press release, Coral executives said the funding round goes toward team and product, with plans to add engineering talent. The company is building an AI workflow builder that lets providers design and deploy their own administrative workflows. And Coral is developing what it describes as a co-pilot layer for the business: a way to surface intelligence from the data it already processes. Release
April 20—Cala Health
Wearable tremor therapy
Series: Unlabeled
Amount: $50 million
Investors: Trinity Capital
Cala Health is a bioelectronic medicine company developing wearable neuromodulation therapies for tremors. It developed and commercialized the Cala kIQ System, an FDA-cleared wearable device designed to help patients manage hand tremors caused by essential tremor and Parkinson's disease.
The device is worn on the wrist and measures a patient's unique tremor pattern and delivers individualized nerve stimulation to counteract tremors through noninvasive electrical stimulation. The therapy is prescribed by physicians for use at home, enabling patients to manage their symptoms outside of a clinical setting and regain the ability to perform everyday activities such as reading, writing, and eating and drinking.
The company plans to accelerate commercial expansion and product innovation, advancing Cala TAPS therapy to impact the lives of essential tremor and Parkinson's disease patients, Cala CEO Deanna Harshbarger said.
April 6—Yuzu Health
Next-generation third-party administrator
Series: A
Amount: $35 million
Investors: General Catalyst and Chemistry led the round, with participation from Anthropic’s Anthology Fund, Bain Future Back Ventures, Timeless Ventures, Lachy Groom, and Neo
Founded in 2022, Yuzu Health initially set out to build a new kind of health plan. As the team built the operational foundation required to run a plan, it identified a broader market gap: the need to modernize the infrastructure behind health insurance to make new types of healthcare plans accessible.
Yuzu Health is now a vertically integrated third-party administrator (TPA) powering claims processing, payments and member administration for health plans. The company says it was built from the ground up with a unified data architecture and offered as a white-labeled solution to enable plans and brokers to launch and scale innovative benefit designs without operational complexity. That foundation allows customers to launch more customizable plan designs — such as direct contracts, cash payment, and dynamic copays — without the heavy services burden of legacy administrators, according to the company.
With the new funding, Yuzu Health will expand its engineering organization and continue to scale its platform nationally. To deepen its role as the system of record for health plan administration, the company will also invest in automating historically manual workflows, such as claims adjudication, stop-loss submissions, reconciliation and bookkeeping, and downstream reporting. Release
April 3—Insight Health
Voice and chat AI agents to handle routine clinical admin work
Series: A
Amount: $11 million
Investors: Standard Capital led the round with participation from Pear VC, Kindred Ventures, Eudemian, ElevenLabs and 43
Insight Health's suite of agents handle time-intensive, routine clinical and non-clinical tasks without the constraints of staffing. Where traditional staffing models require separate personnel for phone and front-desk coordination, referral and fax processing, pre-clinical intake, and clinical documentation, Insight Health seamlessly operates across all of these functions, the company says.
Agents engage with patients directly via voice or text, capturing patient history, medication updates, referral information, and triage for phone-based medical advice. The platform also supports in-visit interactions through a built-in ambient scribe that captures EHR documentation in real time, allowing the clinician to focus on the patient.
Healthcare clinics like The Oregon Clinic, Pacific Sports & Spine, Inland Neurosurgery, Coastal Health and Santiam Hospital are partnering with Insight Health to save administrative teams hundreds of thousands of hours of work each month, reducing annual administrative costs by more than $50 million collectively. Insight Health has completed more than 3 million autonomous clinical conversations with patients across all touchpoints.
With the fresh funding, Insight Health will accelerate product development and expand its partnerships with healthcare organizations across the country, bringing AI-powered administrative relief to more clinical teams at a time when the need is critical for the future of quality healthcare. Release
April 2—AIF
VC for autism, behavioral health
Series: First close of second fund
Amount: $150 million assets under management
AIF, a VC fund for autism, behavioral health and mental health conditions, has reached the first close of its second fund (Fund II).
Launched in 2021, AIF now has approximately $150 million in assets under management with 17 portfolio companies and two successful exits from Fund I. The first fund was $60 million, though AIF has declined to specify the size of the fund because it is the first close.
"We have demonstrated that autism and behavioral health are large and viable investment spaces, where deploying growth capital can deliver market returns and measurable impact at scale, " Chris Male, AIF's co-founder and co-managing partner, said in an announcement. "While public-private partnership is critical to address the complexity of these issues, the private sector must lead the way by putting capital to work," added Mr. Male.
AIF's investment strategy combines delivering market returns through an impact investing model, according to a press release. AIF's existing portfolio includes investments in data and tech-enabled services, innovative service models and life sciences companies.
March
March 31—Jimini Health
Clinician-supervised AI platform for behavioral health
Series: Seed
Amount: $17 million
Investors: M13, Town Hall Ventures, LionBird, Zetta Venture Partners, and OneMind
Jimini Health is building clinician-supervised patient-facing AI infrastructure for large behavioral health provider organizations, enabling providers to deploy patient-facing AI safely, compliantly, and at scale, with licensed clinicians maintaining oversight of every patient interaction.
Patients at large behavioral health systems are already using AI for mental health support between appointments, without clinician visibility or control. This cultural shift is happening regardless of whether providers participate, placing new clinical, operational, and legal pressure on behavioral health organizations to respond.
Jimini’s platform, Sage, is a patient-facing behavioral health AI designed from the ground up for deployment within large clinical organizations, not as a consumer app, but as a supervised member of the care team across the full spectrum of acuity, compliant with federal and state regulations and with clinicians in control, according to the company.
In December 2025, the Centers for Medicare & Medicaid Services (CMS) and the FDA and CMS jointly announced steps to encourage safe clinical AI. With the coordinated ACCESS (CMS) and TEMPO (FDA) programs, CMS and FDA have sent a clear message that they welcome clinical, patient-facing tech-heavy care models.
“As CMS and other payers create new pathways for technology-enabled care, the stakes for getting AI right in behavioral health have never been higher,” said former Acting Administrator of the Centers for Medicare and Medicaid Services under President Obama and Jimini investor Andy Slavitt in a statement. “Jimini is building what the industry needs.”
With the fresh funding, Jimini plans to partner with several of the largest behavioral health provider organizations in the country and expand Sage’s clinical capabilities across comorbidities, care settings, and patient engagement modalities. Release
March 31—Avo
AI solution for clinical workflows and decision support
Series: A
Amount: $10 million
Investors: Noro-Moseley Partners led the round, with participation from existing investors AlleyCorp, Las Olas Venture Capital, MedMountain Ventures, Epsilon Health, and new investor Scrub Capital
Founded at the height of the COVID-19 pandemic, Avo began as a no-code clinical application builder designed to help health systems operationalize their guidelines in the electronic health records. As large language models accelerated AI adoption across healthcare, Avo evolved into a foundational AI platform capable of powering all clinical workflows.
Avo says it serves as a central hub for clinicians, instantly synthesizing relevant patient data, proposing diagnoses and care plans, assisting with orders and documentation, and surfacing evidence-based guidance. With Avo’s copilots such as Chart Assist and Ask Avo, its AI Consult tool, clinicians are supported across entire workflows like admission, discharge, and rounding, freeing them from point solution fatigue.
The company also announced a partnership with EBSCO Clinical Decisions, owner of DynaMed. Through this integration, DynaMed’s expert curated knowledge base will be delivered directly within the Avo platform, enabling clinicians to receive transparent, patient-specific, guideline-aligned recommendations without leaving the EHR. Release
March 23—Doctronic
Integrating AI into healthcare organizations
Series: B
Amount: $40 million
Investors: Co-led by Abstract and Lightspeed Venture Partners.
Doctronic offers consumers free access to an AI doctor and operates its own clinical practice, licensed in all 50 states, HIPAA-compliant, and available 24/7. The startup is now seeing more than 300,000 unique weekly visitors.
The startup partners with major health systems, third-party administrators and self-insured employers across the country. In December, it launched a prescription renewal service in Utah, which allows patients to receive medication refills directly via AI without physician approval. It works with 190 medications and includes clinician escalation for complex cases.
Where the Doctronic AI is practicing medicine independently, such as in Utah, the company says it has a unique AI medical malpractice insurance.
The company says it has direct access to patient records via QHIN/TEFCA, medication history through Surescripts and drug interaction screening through First Databank.
With the series B funding, Doctronic will expand partnerships with hospital systems, academic institutions, digital health platforms and payers. It will also fund expansion into pediatrics, where consumer demand far outpaces access. It's in active discussions with regulators in other states and governments to expand AI prescription services beyond Utah.
"Doctronic proved what we believed from the start: AI can deliver better healthcare outcomes at scale," said Ramtin Naimi, Abstract partner, in a statement. "The Utah program validated their clinical rigor. The revenue growth validated market demand. What sets them apart is the courage to take responsibility for outcomes—not just provide information. That's the future of healthcare."
March 20—Latent Health
Advancing agentic AI for medication access
Series: A
Amount: $80 million
Investors: Co-led by Spark Capital and Transformation Capital, with participation from Conviction, McKesson Ventures, General Catalyst, and Y Combinator
Latent Health aims to use artificial intelligence to speed up the prior authorization process for medications, particularly specialty medications. The company brings clinical intelligence directly into the patient record, helping care teams move patients from clinical decision to therapy faster and more reliably. Latent is used by clinicians, physicians and pharmacists at more than 45 health systems, including Yale New Haven Health, Ochsner Health, MetroHealth, UCI, Vanderbilt Health, Mount Sinai Health System, Henry Ford Health System, UCSF Health and UCLA Health.
The company is building a clinical reasoning engine that performs clinical knowledge work by reasoning through patient data, interpreting drug criteria, extracting key evidence, and orchestrating workflows across stakeholders.
By connecting the EHR, payer guidelines, pharmacy operations and patient engagement with a single engine, Latent replaces the fragmented, manual work that sits between a doctor's order and a patient's treatment with AI agents that perform it instantly and at scale, all to help providers move a patient from decision to therapy the same day, the company said.
Latent started with prior authorization with high provider burnout, high stakes where patients can abandon therapy and complex clinical decision-making. The company is now expanding its engine across every process where clinical knowledge must be translated into action.
With the Series A financing, the company will expand its health system footprint, deepen the platform connecting hospitals, payers, pharmacies, and patients, continue investing in the reliability and trust required to operate in healthcare, and scale the team. Latent is a home for exceptional talent who believe responsibility doesn’t end at diagnosis, it extends to making sure patients actually receive care. Release
March 19—Lantern
Specialty care platform for surgery, infusions, and cancer care
Series: Undisclosed
Amount: $30 million
Investors: Morgan Health, a division of JPMorganChase, and Echo Health Ventures, a strategic investment platform investing on behalf of multiple Blues health plans, led the round.
Lantern, a specialty care platform currently serving 12 million people, saw strong growth in 2025, adding more than 100 new clients representing millions of new member lives. Lantern has also added Thermo Fisher Scientific, Amtrak, Hillsborough County Schools, Cleveland Bakers and Teamsters Health & Welfare Fund, and other national employers.
With the $30 million investment, Lantern plans to expand across public and private employers and health plans.
Lantern's approach centers on its "Network of Excellence" model. Rather than relying solely on traditional centers of excellence – which concentrate care within a limited number of facilities – Lantern negotiates directly with high-quality providers to create the most accessible, high-performing network in the country. Lantern's model works across the three largest cost centers in specialty care: surgery, cancer, and infusions, where site of care shifts combined with high-quality specialists demonstrate savings up to $20 per employee per month (PEPM) across Lantern's customers. Today, Lantern's clients include more than 1,000 of the largest public and private employers and unions in the U.S.
Lantern's platform is designed to lower total medical spend, improve surgical outcomes, reduce downstream costs and provide a better experience for members.
We are restoring basic market dynamics in specialty care to bend the healthcare cost curve," said John Zutter, CEO of Lantern. "We leverage robust cost analytics, clinical data on outcomes, appropriateness measures, and dynamic value-based contracting to get people to great care, close to home."
March 19—Health Universe
Integrating AI into healthcare organizations
Series: Seed
Amount: $6 million
Investors: Led by Kleiner Perkins, follows a pre-seed funding round with participation from Susa Ventures, Twelve Below and Oncology Ventures.
Health Universe, launched in 2023, is an enterprise artificial intelligence platform that automates healthcare workflows.
Its AI platform deploys inspectable, auditable agents to regulated healthcare settings, including for oncology and clinical trials. It is also building an agent-to-agent marketplace. The company's navigator tool, which manages agents that run patient records, has processed more than 170 million clinical documents since its launch less than a year ago.
"Healthcare doesn't need another chatbot," said Dan Caron, Health Universe founder and CEO, in the announcement. "It needs AI systems that are traceable, compliant, and built for real clinical workflows. Our infrastructure allows organizations to deploy agents that solve high-priority use cases quickly, usually in a matter of days or weeks, not months or years. And we provide the security, inspectability, and auditability that academic medical centers and healthcare stakeholders require. This new funding allows us to scale these capabilities and bring trusted AI agents and models to more institutions and health systems across the country."
March 17—Conduit Health
Simplifying DME procurement
Series: A
Amount: $17 million
Investors: Led by Drive Capital, with participation from XYZ Ventures, Twelve Below, Eniac Ventures & others
Conduit Health, launched in 2024, combines clinical evaluation, insurance authorization and medical supply fulfillment in a single coordinated system. For the equipment a patient needs, Conduit connects them to a licensed provider and manages prescribing, coverage verification and delivery. It specifically focuses on Medicare and Medicaid patients.
Its agentic AI platform is trained on over 50,000 patient interactions to predict approval likelihood before claims are filed and automate payer workflows to prevent bottlenecks. The startup works with over 100 payers and takes on denial risk.
It also works with referral partners that include managed long-term services and supports plans and provider organizations.
"The healthcare system makes it nearly impossible for individuals to obtain the home care equipment they need, covered by their insurance. [Cofounders Natan Wise and Rocky Sefte] identified this acute pain point, and the solution the team built feels like magic for the consumer,” Molly Bonakdarpour, general partner at Drive Capital, said in an announcement. “Conduit is easily engaging the hardest to reach patients in healthcare by simply making their lives easier, and it shows in how fast the company is growing.
March 12—Carefam
Automating healthcare HR
Series: Launch from stealth
Amount: $14.5 million
Investors: Pitango HealthTech, Emerge
Carefam, a conversational AI platform for healthcare HR, has launched from stealth. The startup's AI gents are already deployed in hundreds of healthcare orgs across acute care, long-term care and home care settings. Its platform manages the entire HR process on behalf of recruiting teams, using intelligent decision-making to escalate sensitive or complex tasks to humans as needed.
As the healthcare industry faces a workforce crisis, HR teams are overwhelmed by high turnover, manual processes and the complexity of staffing 24/7 operations, Carefam executives said.
“The shortage of healthcare workers today is an infrastructure problem and will continue to worsen if things remain the same,” Matan Hoffmann, co-founder and CEO of Carefam, said in an announcement.
March 11—Translucent
Using AI for insight into financial risk and ways to respond
Series: A
Amount: $27 million
Investors: Led by Google Ventures, with participation from NEA, Virtue, and FPV Ventures.
Translucent, launched in 2024, is the first agentic AI platform used for healthcare finance.
The company uses its platform to consolidate operational, clinical and financial data and continuously monitors for real-time financial insights. The platform is used at healthcare systems across the country, including at Duly Health and Care and Springfield Clinic.
Translucent plans to use funding to accelerate product development and expand its footprint at health systems across the nation.
“Healthcare organizations are in trouble, and the financial infrastructure that should help leaders respond is fundamentally broken. That's why healthcare needs a true financial operating system built for this moment," said Jack O'Hara, Translucent founder and CEO, in a statement. "We built Translucent to give hospitals and clinics what they desperately need: real-time clarity and control, so they can catch problems early enough to act and keep their doors open for the patients who need them.”
March 10—Amigo AI
Training AI clinical agents
Series: A
Amount: $11 million
Investors: Led by Madrona, with participation from Optum Ventures.
Amigo AI is a platform that builds and trains AI agents to directly interact with patients across the spectrum of care, including intake and personalized care navigation.
The platform's agents have completed over three million patient encounters globally with zero safety incidents in the past six months. Amigo has partnered with healthcare organizations around the world, including Eucalyptus and The Care Clinic.
The company partners with healthcare organizations to define AI strategies and build custom agents offered in more than 100 languages.
"Amigo is addressing one of the hardest problems in healthcare AI, deploying autonomous systems where trust and safety are non-negotiable," said Sabrina Albert, Partner at Madrona, in a statement. "Their simulation-first approach to clinical safety positions them to define the standard for patient-facing AI."
March 10—Nitra
AI operating system for healthcare practices
Series: A and B
Amount: $187 million
Investors: Actions Capital, AppWorks, Comma Capital, Dunamu & Partners, Era Funds, New Enterprise Associates (NEA), Pantera Capital, and Sazze Partners. Funding also included participation from AAF, Gaingels, Hyphen Capital, K8, Mana Ventures, Necessary Ventures, PIDC/Uni-President, Purestone Silks, SignalRank, Simu Liu's Markham Valley Ventures, Soma Capital, and others.
Nitra, launched in 2024, embeds AI agents directly into healthcare practices' operational backbones.
The platform is an all-in-one offering that provides healthcare practices with financial automation, patient management and content and inventory. It is used by more than 700 clinics, and is on track to be implemented in 3,000 in 2026.
The company plans to plans to launch additional offerings to the platform in revenue cycle management, patient marketing, payroll and staffing.
"We're on a mission to serve the people that serve our communities and help doctors save time and money," said Tim Hwang, CEO of Nitra, in a statement. "Practices are running critical workflows across disconnected systems that were never designed to work together. Nitra brings those layers together into a single AI-native operating system that helps healthcare practices run their operations more efficiently."
March 5—Sage
AI-powered insights to support senior care
Series: C
Amount: $65 million
Investors: Growth Equity at Goldman Sachs Alternatives, with participation from IVP and Goldcrest.
Sage makes an AI-powered platform for senior living and skilled nursing facilities with the goal of surfacing key insights sooner and moving the industry to a more proactive model of care. Sage has raised $124 million to date.
An estimated 72 million Americans will be of retirement age by 2030. But healthcare faces a shortage of providers and licensed caregivers. Labor alone will not fix this looming crisis, Sage argues. Real-time data insights are crucial to empowering caregivers and helping them intervene in care early. Sage-powered communities have identified a $275 increase in net operating income per resident per month, 50% reduction in falls and 50% faster response times compared to the industry, the company claims.
The latest capital will be used to build out a predictive engine that analyzes daily activity patterns and other fall-risk signals to identify high-risk residents before an adverse event happens. Sage is also working to centralize data from EHRs into a single real-time care view to surface important context at the point of care. Additionally, Sage will deepen its capabilities for skilled nursing facilities, which operate under demanding clinical and regulatory conditions.
“We are experiencing a structural shift in the senior care market, necessitating a complete modernization of its underlying technology,” Antoine Munfa, managing director at Growth Equity, said in an announcement.
“By shifting the industry from a reactive to a proactive model, Sage is creating the scalable infrastructure to help meet the historic demand of an aging population,” said Ryan Leary, Vice President within Growth Equity at Goldman Sachs Alternatives. Release
March 4—UnityAI
Building an autonomous workforce for healthcare operations
Series: A
Amount: $8.5 million
Investors: Third Prime, with participation from Nashville Capital Network, Whistler Capital Partners, Max Ventures, Company Ventures and other existing investors
Companies are quickly deploying AI agents to tackle isolated tasks in healthcare. Taking a different approach, startup UnityAI is building what it calls autonomous operations, with agentic AI that has broader context and capabilities to optimize and continuously manage day-to-day clinic operations from the patient, provider and administrative sides.
UnityAI works with outpatient and specialty care practices to deploy an autonomous AI workforce designed to run core healthcare operations like patient scheduling, follow-ups, referrals and staffing coordination. Its AI agents unify and coordinate fragmented workflows and processes into a single, continuously operating system. These agents work across patient operations – scheduling and rescheduling, confirmations, follow-ups, and referrals and staffing operations – capacity optimization, shift management, PTO and coverage.
“Crossing the ‘last mile’ – actually engaging a person through voice AI to complete a task – has shifted us from simply optimizing workflows to operating them autonomously,” UnityAI co-founder and CEO Edmund Jackson said in a press release.
The company already is operating at nationwide scale, working with large specialty care groups like Tennessee Oncology and Peregrine Health, as well as national dental service organizations, value-based care providers and community and academic health systems. The company supports more than 300,000 patient interactions per month across hundreds of sites of care.
UnityAI touts strong results and ROI from provider deployment of its AI platform. At one national outpatient provider with more than 300 sites, UnityAI’s agentic workforce helped drive a 26% improvement in scheduler productivity and a 30% reduction in no-show rates.
Other measured impacts delivered by UnityAI across all of its customers include 90% of scheduling tasks completed without staff involvement, less than 6% escalation to human teams, 2x higher patient reach rates compared with traditional workflows, 25% increase in converted referrals and 65% workforce savings in supported operational areas.
UnityAI is integrated with major EHR platforms and is continuing to expand its roadmap into additional areas of operational decision-making. This includes staffing coordination capabilities that are now in beta across approximately 75 sites, in addition to advanced scheduling optimization designed to further improve access and efficiency.
The company will use the funding to scale go-to-market execution and extend its AI-powered operational capabilities. - Release
March 2—Ease Health
Re-architecting the behavioral health technology stack
Series: A
Amount: $41 million
Investors: Andreessen Horowitz
Behavioral health providers operate on fragmented, legacy software technology stacks that were not designed for the complexity of today’s modern care delivery. Admissions teams juggle disconnected CRMs and intake tools, clinicians document in EHRs built off paper workflows, and billing teams rely on manual, error-prone workflows.
Ease was built from the ground up to replace this patchwork with one AI-native system purpose-built for behavioral health.
The company’s tech unifies customer relationship management, electronic health record and revenue cycle management into a single platform designed to materially improve access to care, clinician experience, and provider economics across the behavioral health ecosystem.
Ease designed its platform to span the full patient lifecycle, from referral and intake through clinical care, billing and collections. By consolidating what are traditionally six to 10 separate systems into one, Ease reduces administrative overhead, eliminates redundant workflows, and enables automation across the most cost-intensive areas of behavioral health operations, according to the company.
Ease already supports a wide range of behavioral health levels of care, including outpatient, intensive outpatient (IOP), partial hospitalization (PHP), residential treatment, detox, and inpatient psychiatry, as well as medication-assisted treatment (MAT) across applicable settings. Ease works with both independent providers and large, multi-location provider groups, serving organizations across the United States.
The company’s approach has already demonstrated meaningful impact for customers, including reductions in third-party software spend through consolidation, faster time-to-admission, improved clinical documentation efficiency and materially improved billing throughput and collections performance, executives said.
The new funding will be used to expand Ease’s product and engineering teams, accelerate development of AI-powered automation across the platform and support continued growth with enterprise behavioral health providers.- Release
February
Feb. 26—Salma Health
Integrated brain health centers of excellence
Series: A
Amount: $80 million
Investors: Mubadala Capital and ARCH Venture Partners with participation from Lingotto Horizon, as well as others, including Averin Capital
Salma Health launched as a next-generation brain health company that integrates advanced diagnostics, rapid-acting interventions and continuous care coordination under one roof. With the fresh financing, Salma Health is positioned to build and operate centers of excellence designed to fundamentally reshape how brain conditions are diagnosed, treated and studied, the startup said.
Salma Health’s integrated model connects front-line clinical care with scientific research to deliver breakthrough therapies for individuals living with psychiatric and psychological conditions, memory and dementia disorders, headache and migraines and brain injuries.
More than one-third of Americans experience a brain health condition each year. Yet care remains fragmented, siloed and slow, especially for patients whose needs span psychiatry, neurology, psychology and crisis care. Salma Health directly addresses this gap through an integrated, technology-enabled model. The company operates specially equipped clinics for in-person healthcare services augmented by telehealth solutions. These clinics deliver advanced therapeutics, intensive care programs, crisis mitigation and patient support across a full spectrum of psychiatric and neurological services for all levels of acuity.
Salma Health’s model includes clinical research capabilities conducting clinical trials to support pharmaceutical and medical device companies and an AI-driven technology platform. Its Brain Health OS is an intelligent operating system that unlocks clinical insights, enhances decision support and streamlines care coordination. - Release
Feb. 26—Third Way Health
Hybrid AI-human operational efficiency
Series: A
Amount: $15 million
Investors: Health Velocity Capital
Third Way Health developed hybrid human and AI operating solution for healthcare practices, currently supporting practices that collectively serve more than 5 million patients each year.
Today’s healthcare practices are overwhelmed by unprecedented administrative complexity, driven by outdated technology and fragmented processes. The result is widespread staff burnout and subsequent turnover, delayed patient care, and mounting financial pressure for providers and health systems.
The company provides comprehensive front office services, from scheduling to prior authorization, through a white-glove implementation model that transforms operations in as little as 12 weeks. Fully dedicated teams are embedded in clients’ workflows, creating seamless, scalable operational support. To date, Third Way Health has helped clients reduce front-office administrative costs by up to 40%, increase patient visits by 11% on average, and cut phone wait times in half.
Third Way Health will use the funding to accelerate customer growth, expand its operational footprint and further advance its automation roadmap. The company plans to invest in scaling its sales and implementation teams, deepening its AI capabilities and enhancing its platform to support a growing base of customers.
“We are at an inflection point where intelligent automation can truly optimize practices, freeing healthcare providers to focus on patients,” said Frederik Mueller, co-founder and CEO of Third Way Health. “Healthcare practices are ready for solutions that offer sustainable growth, and we are excited to lead the charge. We operate as a true extension of our customers’ teams, moving at their pace, absorbing operational volatility, and advocating relentlessly for what’s best for the practice so that every partnership delivers a genuine win-win. With this funding, we can continue redefining front-office operations and patient care.” - Release
Feb. 25—Baba
Medicare-covered patient advocacy platform
Series: Seed
Amount: $6.5 million
Investors: General Catalyst, with participation from Genius Ventures, Soma Capital, Ground Up Ventures, Triedge Investments and others
Startup Baba emerged from stealth funded with $6.5 million in seed funding to address a growing gap help older adults navigate care.
The company developed a Medicare- and Medicare Advantage-covered patient advocacy platform that assigns dedicated human advocates to work longitudinally with patients and caregivers, positioning patient advocacy as reimbursable healthcare infrastructure rather than a private-pay add-on.
While healthcare coverage may exist, many older adults still struggle to navigate insurance appeals, coordinate across providers, and manage follow-through after discharge.
To date, Baba has supported more than 6,000 families navigating complex care needs. The company partners with nursing homes, home care agencies and home health organizations nationwide to connect patients with Baba’s dedicated advocates during care transitions. Baba is enrolling in an IRB-approved clinical study with Johns Hopkins to independently evaluate the impact of its advocacy model on health and claims outcomes.
The new capital will support expansion across Medicare and Medicare Advantage populations and deepen partnerships in provider and post-acute settings.
Baba's advocates, who are usually nurses or social workers, manage the operational breakdowns that most often derail care plans, including insurance challenges, scheduling issues and care coordination, while working alongside providers rather than outside the system.
Baba also offers a phone- and text-based AI companion that provides daily engagement, reminders, and early signals when barriers to care arise, allowing advocates to intervene quickly and manage follow-through. Release
Feb. 19—Frist Cressey Ventures
Fund focused on early-stage, tech-driven companies
Series: Fund IV
Amount: $425 million
Investors: N/A
FCV's oversized fund close brings the venture capital firm's total assets under management to nearly $1 billion. The new fund will drive the firm's focus on early-stage companies focused on transforming care delivery with tech and tech-enabled services, including AI-native business models.
"As we enter this next chapter, we're excited to build strong, transformative, and enduring partnerships – and to serve as a trusted partner to the leaders and companies shaping the future of patient-centered care," Former Sen. Bill Frist, M.D., co-founder and managing partner at FCV, said in the announcement.
The firm celebrates its 10-year anniversary this year. It has made 44 investments and has seen 14 successful exits. FCV has partnered with The Cigna Group Ventures, MedStar Health and OhioHealth. Its strategic LPs collectively provide healthcare to over half the U.S. population.
Feb. 17—Daffodil Health
AI for health plan admin, claims processing
Series: A
Amount: $16.3 million
Investors: Led by Flare Capital Partners, with participation from LRVHealth and Maverick Ventures, plus individual investors.
The capital will be used for product development and to expand work with payers and third-party administrators. Daffodil aims to help with price transparency, automated negotiations and real-time claims support. The startup argues legacy claims systems can't support the flexible plan designs growing popular.
“For too long, health plans have been unable to meaningfully address the healthcare cost crisis because they’ve been forced to pay high fees to middlemen whose incentives often make the problem worse,” Navin Nagiah, CEO and co-founder of Daffodil Health, said in an announcement. "By giving plans control over pricing logic and real visibility into claims, we’re striving for more transparent, auditable, and cost-effective benefit design across the board.”
Daffodil uses AI and large language models to help clients bring out-of-network repricing and payment integrity in-house, with minimal or no increases in labor costs. Across current partnerships, Daffodil claims to deliver seven-figure improvements in plan margins. One payer partner has saved about $4 million in the first year of the partnership solely through vendor fee reductions.
Feb. 13—Big Health
Digital therapeutics for mental health
Series: Undisclosed
Amount: $23.7 million
Investors: .406 Ventures and AlleyCorp led the round, with participation from CVS Health Ventures, Blue Venture Fund, Sandbox Clinical Ventures, Gilde Healthcare and Supermoon Capital.
Digital therapeutics developer Big Health plans to use the funding to accelerate access to its FDA-cleared, reimbursable solutions (SleepioRx for insomnia disorder and DaylightRx for generalized anxiety disorder). SleepioRx and DaylightRx are among just nine FDA-cleared treatments in the Centers for Medicare & Medicaid Services' (CMS') recently established category of digital mental health treatments (DMHTs), a new class of reimbursable medical device treatments for mental health conditions. Big Health’s latest funding follows the CMS DMHT policy, which created new G-codes in the 2025 Physician Fee Schedule, enabling the first national Medicare coverage for FDA-cleared DMHTs such as SleepioRx and DaylightRx. Release
Feb. 12—Talkiatry
Telepsychiatry provider
Series: D
Amount: $210 million
Investors: Perceptive Advisors led the round, which the company said was oversubscribed. Brussels-based investor Sofina also participated along with prior lead investors Andreessen Horowitz (a16z), blisce/ and Left Lane Capital, alongside a debt facility from Banc of California.
The company claims to be the largest private employer of psychiatrists and directly employs more than 800 full-time psychiatrists. Talkiatry is now in network with more than 100 insurers nationwide covering more than 170 million lives. The company has delivered 3 million patient visits to date. Talkiatry plans to use the fresh funding to build out its technology and expand its services across the acuity spectrum. Article
Feb. 12—Anterior
AI platform for health plans
Series: Undisclosed
Amount: $40 million
Investors: NEA and Sequoia Capital alongside new investors FPV and Kinnevik
Anterior works with health insurers to deploy artificial intelligence technology within the clinical workflow and pairs that tech with a clinician-led team that supports payers in optimizing accuracy and driving measurable impacts. Anterior founder and CEO Abdel Mahmoud, M.D., said the platform is designed to ease the back-office burden for health plans, including prior authorization, payment integrity and risk adjustment. Article
Feb. 10—Solace Health
Patient advocacy platform
Series: C
Amount: $130 million
Investors: IVP led the round with participation from existing investors Menlo Ventures, SignalFire, Torch Capital, Inspired Capital and RiverPark Ventures.
Solace Health connects Medicare and Medicare Advantage patients to trained healthcare advocates to improve their experience navigating the healthcare system and assist them in getting the care they need. Patients are matched with advocates on Solace Health’s digital platform. With the additional funds, Solace Health hopes to expand its national advocate network beyond its 2,000 existing advocates. Article
Feb. 10—Garner Health
Digital care navigation company for employers
Series: D
Amount: $118 million
Investors: Kleiner Perkins led the round, with Redpoint, Maverick, Kaiser Permanente Ventures, Mercy, Plus Capital and other existing investors also participating.
Founded in 2019, Garner uses data analytics and artificial intelligence to help employers and employees identify high-quality, cost-effective healthcare providers and then creates financial incentives for patients to see those doctors. It plans to use the fresh capital to expand its doctor ranking platform, scale its AI-driven navigation and appointment booking capabilities and grow its team. Article
Feb. 4—Chamber Cardio
Value-based care for cardiology practices
Series: A
Amount: $60 million
Investors: Frist Cressey Ventures led the series A round. Existing investors General Catalyst, AlleyCorp, American Family Ventures and Company Ventures also backed the round along with strategic participation from Optum Ventures, Healthworx Ventures and additional investment from Black Opal Ventures. The financing also includes debt from HSBC Innovation Banking.
The startup, which launched in 2022, provides cardiologists with a tech solution along with infrastructure for administrative and care team support and helps practices navigate value-based contracting. It plans to use the funding to build out its tech-enabled delivery platform that supports cardiologists in value-based care models. Article
Feb. 3—Midi Health
Virtual women's health clinic
Series: D
Amount: $100 million
Investors: Goodwater Capital led the round, new investors Foresite Capital and Serena Ventures and existing investors Advance Venture Partners, GV (Google Ventures), Emerson Collective, SemperVirens and McKesson Ventures also backed the round.
The five-year-old startup, a Fierce 15 of 2025 honoree, is building a comprehensive healthcare platform that serves women across every life stage with an ongoing focus on midlife women’s health conditions. The company plans to offer new care lines addressing metabolic health, weight management, musculoskeletal health and long-term wellness. Article
Feb. 3—Lotus Health AI
AI doctor for primary care
Series: A
Amount: $35 million
Investors: Kleiner Perkins and CRV co-led the round, with backing from Joe Montana’s Liquid 2, Adidas Family Office’s LEADVC and a group of high-profile healthcare and technology founders and operators, including Jerry Murdock, Michael Ovitz, Aneesh Chopra, Vivek Garipalli, Othman Laraki, Travis May, Julia Cheek, Adrian Aoun, Harpreet Rai, Colin Evans, Jacob Reider, Harjinder Sandhu and Ian Shakil, alongside physicians from Harvard and Stanford.
Kleiner Perkins also led Lotus' seed round, bringing total funding to $41 million. Lotus Health AI built an "AI doctor" that provides free primary care 24/7 in more than 50 languages. Lotus Health AI combines medical AI, unified patient health data, the latest peer-reviewed medical evidence, clinical guidelines and board-certified physicians reviewing guidance. The system automatically syncs medical records, labs, medications, wearable data and insurance benefits into one secure profile. Physicians review care, refine recommendations and prescribe medications when needed. The company plans to add lab ordering and in-person care routing. Lotus Health AI will use the capital to build out the infrastructure, clinical team and the runway for its AI-powered primary care model. Release
Feb. 3—Alaffia Health
Agentic AI for health plan claims operations
Series: B
Amount: $55 million
Investors: Transformation Capital, with participation from insiders including FirstMark Capital, Tau Ventures and Twine Ventures
Founded in 2020 by sibling duo TJ Ademiluyi and Adun Akanni, Alaffia was built to address these challenges, drawing on firsthand experience growing a family business focused on revenue cycle management. Alaffia partners with leading regional and national health plans to help them scale clinical review capacity and unlock significant savings. Alaffia has delivered millions of dollars in medical cost savings, reduced turnaround times from weeks to days and improved consistency across findings. The startup will use the new capital to invest in R&D, launch new artificial intelligence agents across additional modalities to expand platform capabilities and scale AI adoption to meet rising demand across the healthcare ecosystem. Release